Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Liver Cancer|Pancreatic Cancer|Brain Tumor|Breast Cancer|Ovarian Tumor|Colorectal Cancer|Acute Myeloid and Lymphoid Leukemias
Interventions: BIOLOGICAL: anti-CD133-CAR vector-transduced T cells
Sponsor: Chinese PLA General Hospital